[go: up one dir, main page]

ES2522823B2 - Use of polymerized protein particles generated from prion protein for the treatment of prionopathies - Google Patents

Use of polymerized protein particles generated from prion protein for the treatment of prionopathies Download PDF

Info

Publication number
ES2522823B2
ES2522823B2 ES201330557A ES201330557A ES2522823B2 ES 2522823 B2 ES2522823 B2 ES 2522823B2 ES 201330557 A ES201330557 A ES 201330557A ES 201330557 A ES201330557 A ES 201330557A ES 2522823 B2 ES2522823 B2 ES 2522823B2
Authority
ES
Spain
Prior art keywords
protein
prionopathies
treatment
particles generated
polymerized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201330557A
Other languages
Spanish (es)
Other versions
ES2522823A1 (en
Inventor
Miguel Ángel PASTRANA GONZÁLEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES201330557A priority Critical patent/ES2522823B2/en
Priority to PCT/ES2014/070313 priority patent/WO2014170521A1/en
Publication of ES2522823A1 publication Critical patent/ES2522823A1/en
Application granted granted Critical
Publication of ES2522823B2 publication Critical patent/ES2522823B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES201330557A 2013-04-18 2013-04-18 Use of polymerized protein particles generated from prion protein for the treatment of prionopathies Active ES2522823B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201330557A ES2522823B2 (en) 2013-04-18 2013-04-18 Use of polymerized protein particles generated from prion protein for the treatment of prionopathies
PCT/ES2014/070313 WO2014170521A1 (en) 2013-04-18 2014-04-15 Use of polymerised protein particles generated from prion protein for the treatment of prion diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201330557A ES2522823B2 (en) 2013-04-18 2013-04-18 Use of polymerized protein particles generated from prion protein for the treatment of prionopathies

Publications (2)

Publication Number Publication Date
ES2522823A1 ES2522823A1 (en) 2014-11-18
ES2522823B2 true ES2522823B2 (en) 2015-12-01

Family

ID=51730851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201330557A Active ES2522823B2 (en) 2013-04-18 2013-04-18 Use of polymerized protein particles generated from prion protein for the treatment of prionopathies

Country Status (2)

Country Link
ES (1) ES2522823B2 (en)
WO (1) WO2014170521A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002246734A1 (en) * 2000-12-27 2002-08-12 University Of Texas Health Science Center Houston Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
DE60121729T2 (en) * 2001-04-19 2007-11-29 Dr. Hermann Schätzl Prion protein dimers for vaccinations

Also Published As

Publication number Publication date
ES2522823A1 (en) 2014-11-18
WO2014170521A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
IL243632B (en) Peptide-conjugated particles
PL3004155T3 (en) THE PEPTIDE COMPOUND
EP3052140A4 (en) NON-SELF-ADHESIVE COATING MATERIALS
EP2970372A4 (en) MODIFIED LYMPHOCYTES
EP3736015C0 (en) DEVICES FOR THE DELIVERY OF COMPACT AGENTS
EP2953431A4 (en) PLASMA GENERATOR
HRP20181213T1 (en) THE PEPTIDE MIXTURE
DK2970389T3 (en) Pharmaceutical compounds
EP2970418A4 (en) EZH2 PEPTIDE STABILIZED
LT3563837T (en) THERAPY FOR BACTERIOPHAGA
HUE048088T2 (en) New antibody against netrin-1
CL2014003052A1 (en) Antibodies for the neutralization of influenza
FR3025517B1 (en) LIGANDS POTENTIATING THE BIOACTIVITY OF GONADOTROPHINS
EP3037112A4 (en) PROSTHESIS
MA41266A (en) POULTICE
LT3030259T (en) PEPTIDES
FR3026388B1 (en) AIRCRAFT LANDFILL
ES1082255Y (en) PERFECTED HIP PROTESIS
IL249270A0 (en) Artificial bracket
PL2981429T3 (en) MODULAR SYSTEM OF THE OPERATING DEVICE
FR3005989B1 (en) AIRCRAFT TURBOPROPOWER
FI20136038L (en) New materials
FR3009951B1 (en) INTRA-LARYNGEAL PROSTHESIS
DK3164118T3 (en) COATED PARTICLES
FR3018502B1 (en) AIRCRAFT LANDFILL

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2522823

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20151201